Multicenter screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation: comparison with <scp>NICE</scp> guidelines and <scp>ACOG</scp> recommendationsN. O’Gorman, K. H. Nicolaides, Daniel L. Rolnik et al.|Ultrasound in Obstetrics and Gynecology|2017Cited by 363
Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsiaD. Wright, K. H. Nicolaides, Evgenia Kapeti et al.|American Journal of Obstetrics and Gynecology|2017Cited by 166
Prediction of pre‐eclampsia in twin pregnancy by maternal factors and biomarkers at 11–13 weeks' gestation: data from <scp>EVENTS</scp> trialZ. Benkő, K. H. Nicolaides, Jesica Aguilera et al.|Ultrasound in Obstetrics and Gynecology|2020Cited by 46
First-Trimester Combined Multimarker Prospective Study for the Detection of Pregnancies at a High Risk of Developing Preeclampsia Using the Fetal Medicine Foundation-AlgorithmMeriem Guizani, Jacques Jani, Joseph Valsamis et al.|Fetal Diagnosis and Therapy|2017Cited by 43
<scp>STATIN</scp> trial: predictive performance of competing‐risks model in screening for pre‐eclampsia at 35–37 weeks' gestationMoritz Döbert, K. H. Nicolaides, Alan Wright et al.|Ultrasound in Obstetrics and Gynecology|2021Cited by 31